Dose-dependent severe cutaneous reactions to imatinib
The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of four melanoma patients treated with high-dose imatinib presenting with severe and strongly dose-dependent skin eruptions, suggesting a cutan...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 April 2003
|
| In: |
British journal of cancer
Year: 2003, Jahrgang: 88, Heft: 8, Pages: 1157-1159 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/sj.bjc.6600893 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.bjc.6600893 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/6600893 
|
| Verfasserangaben: | S. Ugurel, R. Hildenbrand, E. Dippel, A. Hochhaus and D. Schadendorf |
| Zusammenfassung: | The protein kinase inhibitor imatinib has been approved as an efficient anticancer drug with common but mild cutaneous toxicities. We here report on two out of four melanoma patients treated with high-dose imatinib presenting with severe and strongly dose-dependent skin eruptions, suggesting a cutaneous reactivity pattern different from allergic hypersensitivity. |
|---|---|
| Beschreibung: | Gesehen am 18.11.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/sj.bjc.6600893 |